We are live on ! Find out more
LUXA

Lux Health Tech Acquisition Corp. Class A Common Stock
LUXA

Delisted

LUXA was delisted on the 28th of October, 2022.

Back to rankings

Fund managers haven’t disclosed any holdings of LUXA yet.

LUXA Hedge Fund Activity: Q4 2022 in Review

0 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) for Q4 2022, worth a combined $0 — down 100% from $301M a quarter earlier.

Sellers outnumbered buyers: 72 funds closed out of LUXA and 0 opened new positions — a net loss of 72 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Empyrean Capital Partners, exiting entirely with an estimated $30.1M sold.

  • 0 institutional investors held Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) as of Q4 2022, down from 72 in Q3 2022.
  • Funds reported $0 of Lux Health Tech Acquisition Corp. Class A Common Stock stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Lux Health Tech Acquisition Corp. Class A Common Stock positions in Q4 2022 and 72 closed out, a net change of -72 holders.
  • The largest Lux Health Tech Acquisition Corp. Class A Common Stock seller in Q4 2022 was Empyrean Capital Partners, an estimated $30.1M sold.

Based on aggregated 13F filings for Q4 2022.